TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
CBUS

Cibus Global LLC

Healthcare · Biotechnology

1.70$ -1.8% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Cibus Global LLC (CBUS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 313 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CBUS
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– 17 15 17 76 72 72 129 125 119 111 104 96 88 76 68 62 63 52 48 40 37 38 32 27 22 20 814 796 544 533 553 368 350 335 346 330 305 324 313
– 5.5 3.7 5.3 63 57 53 107 103 96 87 79 72 64 52 44 38 40 29 25 17 15 19 13 7.9 4.1 2.6 55 34 35 27 33 32 17 26 40 26 12 33 23
– 5.0 3.0 2.5 63 57 51 106 102 94 84 76 66 59 7.4 3.9 7.2 17 16 17 14 14 17 11 7.0 3.4 2.1 51 32 33 25 30 29 14 24 36 24 9.9 30 20
– 5.0 3.0 2.5 63 57 51 106 102 94 84 76 66 59 46 34 28 29 19 17 14 14 17 11 7.0 3.4 2.1 51 32 33 25 30 29 14 24 36 24 9.9 30 20
– 0.2 0.0 0.1 0.1 0.2 0.0 0.1 0.2 0.0 0.3 0.9 1.4 1.1 0.8 2.4 2.4 4.9 1.4 4.0 0.2 – – – – 0.0 – 0.9 0.6 0.5 0.9 1.3 1.2 1.0 1.0 1.0 0.6 0.7 1.8 0.8
– 0.8 – 2.1 – 1.3 – – 0.1 1.3 0.4 0.1 2.4 2.6 3.2 5.3 6.0 1.4 4.5 2.5 1.7 – – – – – – – – – – – – – – – – – – –
– 4.3 – – – 4.1 – – 4.7 – – – – – – – – – – – – – – – 19 18 – 38 – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – – – – 0.0 – 585 585 435 435 435 253 253 233 233 233 233 233 233
– – – – – – – – – – – – – – – – – – – – – – – – – 0.2 – 135 135 35 35 34 34 34 33 33 32 32 31 31
– 3.5 4.7 9.4 13 15 18 23 24 25 23 23 24 26 24 24 28 26 27 26 24 23 23 18 18 15 18 193 204 206 213 246 247 252 261 272 278 283 289 299
– 2.9 4.0 8.9 5.1 4.3 3.0 5.0 6.9 7.0 4.7 5.0 5.8 7.2 5.6 4.6 7.9 6.9 6.3 7.2 5.1 4.9 9.5 4.5 4.2 1.7 4.2 22 25 21 22 29 22 20 21 22 21 17 14 14
– – – – – 1.4 – – – 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.3 0.2 0.1 0.5 1.4 6.8 6.8 13 6.7 8.3 4.6 4.8 4.9 4.1 3.4 3.2 3.0 3.7
– 0.4 0.7 1.9 0.6 1.0 0.4 1.1 1.2 0.8 0.7 0.4 0.9 1.1 1.1 0.6 1.2 0.9 1.0 2.2 1.0 1.3 1.2 0.5 0.4 0.3 0.3 4.0 6.3 6.1 6.7 6.2 7.0 6.0 6.8 5.9 6.0 8.1 5.4 5.6
– 0.5 – – – 0.2 – – 0.6 – – – – – – – – – – – – – – – – – – 0.7 0.6 0.5 0.4 0.4 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1
– 13 10 7.6 62 57 54 106 100 93 88 80 72 63 53 44 35 37 26 22 16 14 15 14 8.8 7.2 2.7 484 463 293 278 270 108 92 70 72 50 22 35 15
– -29 -31 -35 -48 -55 -59 -66 -74 -82 -90 -99 -110 -122 -133 -144 -153 -167 -177 -182 -189 -196 -201 -203 -209 -212 -218 -236 -263 -480 -503 -528 -708 -731 -778 -803 -827 -858 -879 -902
11 11 11 10 10 11 11 12 13 13 13 13 13 13 13 13 13 15 15 15 15 15 12 12 12 12 12 12 16 17 21 22 24 27 23 42 53 53 65 77

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?